Ravicher attacks Myriad over BRCA patents
Dan Ravicher of the Public Patent Foundation this week claimed his actions “help the patent system maintain credibility for society” in a debate over his pending patent dispute with Myriad Genetics
Ravicher and the American Civil Liberties Union (ACLU) are
representing a number of breast cancer and women's health
groups, individual women, geneticists and scientific
associations in a suit against Myriad.
The suit alleges that some claims of Myriad's seven
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.